GSK plc American Depositary Shares (GSK)
sell disclosed on 10 Sept 2025 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +7.5%
Public insider research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Insider research history
Robert B. Aderholt
Public disclosure history for this insider, with previous signal outcomes and source links kept visible for research review.
3 disclosures
1 buy
2 sells
-5.5% avg. 30d outcome (3 of 3)
Insider facts
- Role
- Representative
- Country
- US
- Party
- Republican
- Type
- POLITICIAN
- Repeat disclosures
- 0
Politician review
Historical research metrics from promoted public disclosures only. This is not investment advice.
93% avg. data confidence
- Hypothetical 30d win rate
- 1 of 3 positive outcomes
- Best reviewed outcome
- +7.5% best 30d outcome
- Weakest reviewed outcome
- -23.2% weakest 30d outcome
Repeated sectors
- Unclassified, 3 disclosures
Repeated companies
No repeated companies yet.
Disclosure history
Tesla, Inc. - Common Stock (TSLA)
sell disclosed on 13 Dec 2022 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -23.2%
Apple Inc. - Common Stock (AAPL)
buy disclosed on 23 Sept 2022 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -0.7%